RESULTS
Participants
Twenty children with challenge-confirmed peanut allergy, mean age of 8.2 (SD, 3.0) years were enrolled (Table 1). Four children withdrew during treatment (additional details in supporting information); 16 completed 18-months of treatment and attended the end-of-treatment (T2) and 8-week post-treatment (T3) DBPCFCs; 14 completed T4 and/or T5 DBPCFC (Figure 1).